DiaMedica Therapeutics (DMAC) Interest Coverage Ratio (2018 - 2026)
DiaMedica Therapeutics (DMAC) posted quarterly Interest Coverage Ratio of 455.74 for Q1 2026, up 94.4% year-over-year from 234.43 in Q1 2025, and down 130883.57% quarter-over-quarter from 0.35 in Q4 2025.
DiaMedica Therapeutics (DMAC) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics' Interest Coverage Ratio history runs 9 years deep, the most recent figure standing at 455.74 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 94.4% year-over-year to 455.74; the TTM figure through Mar 2026 stood at 854.3 (up 41.25% YoY), while the FY2025 annual figure was 0.81, down 3.91% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 455.74, down from 0.35 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 0.35 in Q4 2025, with the low at 8144.0 in Q1 2025.
- The 5-year median for Interest Coverage Ratio is 6.23 (2023), against an average of 784.16.
- The sharpest annual moves came in 2022 and 2023: Interest Coverage Ratio sank 545981.9% in 2022, then soared 98.65% in 2023.
- DiaMedica Therapeutics' Interest Coverage Ratio stood at 4.78 in 2022, then sank by 47.19% to 7.03 in 2023, then soared by 88.31% to 0.82 in 2024, then surged by 57.67% to 0.35 in 2025, then sank by 130883.57% to 455.74 in 2026.
- Business Quant data shows DMAC's Interest Coverage Ratio at 455.74 in Q1 2026, 0.35 in Q4 2025, and 0.43 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | DiaMedica Therapeutics | 360.22 Mn | 360.22 Mn | - | -0.52 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.52 |
| Mar 31, 2026 | -455.74 |
| Dec 31, 2025 | -0.35 |
| Sep 30, 2025 | -0.43 |
| Jun 30, 2025 | -2.13 |
| Mar 31, 2025 | -8,144.00 |
| Dec 31, 2024 | -0.82 |
| Sep 30, 2024 | -1.41 |
| Jun 30, 2024 | -5.44 |
| Mar 31, 2024 | -302.16 |
| Dec 31, 2023 | -7.03 |
| Sep 30, 2023 | -11.16 |
| Jun 30, 2023 | -1.27 |
| Mar 31, 2023 | -47.59 |
| Dec 31, 2022 | -4.78 |
| Sep 30, 2022 | -26.29 |
| Mar 31, 2022 | -3,536.00 |
| Dec 31, 2021 | -190.94 |
| Sep 30, 2021 | -13.56 |
| Jun 30, 2021 | -42.59 |